Analyst Price Targets — SYRS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 23, 2024 7:41 am | Edward Tenthoff | Piper Sandler | $5.00 | $2.47 | StreetInsider | Piper Sandler Reiterates Overweight Rating on Syros Pharmaceuticals (SYRS) |
| June 26, 2024 7:48 am | Edward Tenthoff | Piper Sandler | $13.00 | $5.70 | StreetInsider | Piper Sandler Reiterates Overweight Rating on Syros Pharmaceuticals (SYRS) |
| June 26, 2024 6:39 am | Andrew Fein | H.C. Wainwright | $15.00 | $5.70 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Syros Pharmaceuticals (SYRS) |
| August 9, 2022 6:22 pm | Mark Breidenbach | Oppenheimer | $30.00 | $9.27 | TheFly | Syros Pharmaceuticals price target lowered to $3 from $9 at Oppenheimer |
No recent news available for SYRS.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SYRS.
U.S. House Trading
No House trades found for SYRS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.